Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

Market Cap	4.75B +8.2%
Revenue (ttm)	3.66B +28.6%
Net Income	249.95M -11.9%
EPS	0.77 -3.6%
Shares Out	296.60M
PE Ratio	20.73
Forward PE	14.98
Dividend	0.40 (2.50%)
Ex-Dividend Date	Sep 29, 2025

Volume	1,830,444
Average Volume	3,696,611
Open	15.98
Previous Close	16.03
Day's Range	15.89 - 16.25
52-Week Range	13.11 - 20.20
Beta	0.59
RSI	49.38
Earnings Date	Apr 24, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 1,350
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605077

Financial Performance

In 2024, SHA:605077's revenue was 2.81 billion, an increase of 0.93% compared to the previous year's 2.78 billion. Earnings were 268.48 million, a decrease of -27.72%.